A phase II study of iproplatin in advanced or metastatic stomach cancer. The EORTC Early Clinical Trial Group.
Sessa
C
C
Ospedale San Giovanni, Bellinzona, Switzerland.
Cerny
T
T
Kaye
S
S
Monfardini
S
S
Rénard
J
J
Cavalli
F
F
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009944:Organoplatinum Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; C023359:iproplatin